SCHEMBL25689073

SCHEMBL25689073

c1ccc(-c2ccc3[nH]c4ccc5oc6ccccc6c5c4c3c2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK4 P11802 2/20 0.51
▸ CCND1 P24385 2/20 0.51
▸ PLA2G2A P14555 5/20 0.47
▸ PLA2G4A P47712 5/20 0.47
▸ CASP3 P42574 1/20 0.45
▸ SENP7 Q9BQF6 1/20 0.45
▸ SENP6 Q9GZR1 1/20 0.45
▸ KDM4E B2RXH2 1/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ GAA P10253 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ PLA2G10 O15496 1/20 0.42
▸ HCRTR1 O43613 1/20 0.39
▸ JAK2 O60674 1/20 0.39
▸ GABRP O00591 2/20 0.38
▸ GABRD O14764 2/20 0.38
▸ GABRA1 P14867 2/20 0.38
▸ GABRB1 P18505 2/20 0.38
▸ GABRG2 P18507 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22954029 0.95 CDK4 (0.52) CDK4CCND1PLA2G2APLA2G4ACASP3
SCHEMBL24728572 0.94 CDK4 (0.54) CDK4CCND1PLA2G2APLA2G4ACASP3
SCHEMBL25996378 0.91 CDK4 (0.48) CDK4CCND1PLA2G2APLA2G4ACASP3
SCHEMBL24027684 0.89 CDK4 (0.44) CDK4CCND1PLA2G2APLA2G4ACASP3
SCHEMBL25681398 0.87 GABRP (0.47) CDK4CCND1PLA2G2APLA2G4ACASP3
SCHEMBL16745243 0.86 PLA2G2A (0.50) CDK4CCND1PLA2G2APLA2G4ACASP3
SCHEMBL23030716 0.86 CDK4 (0.46) CDK4CCND1PLA2G2APLA2G4ACASP3
SCHEMBL25703026 0.84 PLA2G2A (0.46) CDK4CCND1PLA2G2APLA2G4ACASP3
SCHEMBL25704074 0.83 CASP3 (0.39) CDK4CCND1PLA2G2APLA2G4ACASP3
SCHEMBL18666426 0.83 CDK4 (0.50) CDK4CCND1PLA2G2APLA2G4ACASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230265106-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT KYULUX, INC. (JP) 2023-08-24 — — US disclosed
EP-4190791-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT Kyulux, Inc. (JP) 2023-06-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230265106-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT CRY1, CCNE2, CRY2 CDK4 26/4885CCND1 20/4885PLA2G2A 4566/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback